Next Article in Journal
Gadoxetic Acid-Based MRI for Decision-Making in Hepatocellular Carcinoma Employing Perfusion Criteria Only—A Post Hoc Analysis from the SORAMIC Trial Diagnostic Cohort
Next Article in Special Issue
Low Platelet Count Predicts Reduced Survival in Potentially Resectable Hepatocellular Carcinoma
Previous Article in Journal
An Unexpected Tumor Reduction: Treatment with Olaparib Monotherapy in Heavily Pretreated BRCA2 Mutated Metastatic Pancreatic Cancer
Previous Article in Special Issue
Pretreatment Neutrophil-to-Lymphocyte Ratio as a Predictive Marker of Response to Atezolizumab Plus Bevacizumab for Hepatocellular Carcinoma
 
 
Review

Article Versions Notes

Curr. Oncol. 2022, 29(2), 551-564; https://doi.org/10.3390/curroncol29020050
Action Date Notes Link
article xml file uploaded 27 January 2022 14:54 CET Original file -
article xml uploaded. 27 January 2022 14:54 CET Update https://www.mdpi.com/1718-7729/29/2/50/xml
article pdf uploaded. 27 January 2022 14:54 CET Version of Record https://www.mdpi.com/1718-7729/29/2/50/pdf
article html file updated 27 January 2022 14:55 CET Original file -
article html file updated 31 July 2022 06:56 CEST Update https://www.mdpi.com/1718-7729/29/2/50/html
Back to TopTop